Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...
The Associated Press on MSN5d
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContinMembers of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...
A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.
Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...
Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.
The freeze also prohibited the publication of scientific studies and research reports, including the CDC’s Morbidity and Mortality Weekly Report. KFF Health News reported that – until now – the ...
Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...
Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...
Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results